Loading companies…
RI
ReEmerge, Inc.
United States · Healthtech · Biotech
ReEmerge is developing Cognitive Network Restoration Therapy (CNRT) for people with chronic cognitive impairment after brain injury. The treatment targets underactive but viable neural circuits in the central thalamus to restore function across disrupted brain networks; the company is advancing this restorative approach through clinical development.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $37M | Santé — LeadU.S. Venture Partners — Lead415 Capital — ParticipantDendrion Ventures — ParticipantIAG Capital Partners — ParticipantOxford Science Enterprises — ParticipantThe Vertical Group — Participant |
Investors
SantéLed Series AU.S. Venture PartnersLed Series A415 CapitalJoined Series ADendrion VenturesJoined Series AIAG Capital PartnersJoined Series AOxford Science EnterprisesJoined Series AThe Vertical GroupJoined Series ACoverage
Sep 15, 2026ReEmerge, Inc. · Series ASimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed